(Q43054722)

13 November 2017

Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty - a 5-year follow-up of 16 patients (English)

1 reference

13 November 2017

T S Tapaninen

1

1 reference

13 November 2017

P K Venesmaa

2

1 reference

13 November 2017

J S Jurvelin

3

1 reference

13 November 2017

H J A Miettinen

4

1 reference

13 November 2017

H P J Kröger

5

1 reference

13 November 2017

1 January 2010

1 reference

Scandinavian Journal of Surgery

13 November 2017

1 reference

13 November 2017

99

1 reference

13 November 2017

1

1 reference

13 November 2017

32-37

1 reference

Fatigue failure of cancellous bone: a possible cause of implant migration and loosening

13 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Measurement of bone mineral density by dual-energy x-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry--a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Ten years' experience with alendronate for osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

Does bone quality predict loosening of cemented total hip replacements?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691009900108

10.1177/145749691009900108

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference